Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ontario And NotCarlos Singer

List of bibliographic references

Number of relevant bibliographic references: 201.
Ident.Authors (with country if any)Title
000021 Alfonso Fasano [Canada] ; Günther Deuschl [Allemagne]Therapeutic advances in tremor.
000054 Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie]Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
000066 Antonella Conte [Italie] ; Gina Ferrazzano [Italie] ; Nicoletta Manzo [Italie] ; Giorgio Leodori [Italie] ; Giovanni Fabbrini [Italie] ; Alfonso Fasano [Canada] ; Michele Tinazzi [Italie] ; Alfredo Berardelli [Italie]Somatosensory temporal discrimination in essential tremor and isolated head and voice tremors.
000089 Anosha Zanjani [Canada] ; Konstantine K. Zakzanis [Canada] ; Zafiris J. Daskalakis [Canada] ; Robert Chen [Canada]Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.
000122 Kaviraja Udupa [Canada] ; Susan H. Fox [Canada]Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.
000171 Helen Ling [Royaume-Uni] ; Yasmine T. Asi [Royaume-Uni] ; Igor N. Petrovic [Royaume-Uni] ; Zeshan Ahmed [Royaume-Uni] ; L K Prashanth [Canada] ; Lili-Naz Hazrati [Canada] ; Masatoyo Nishizawa [Japon] ; Tetsutaro Ozawa [Japon] ; Anthony Lang [Canada] ; Andrew J. Lees [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni]Minimal change multiple system atrophy: an aggressive variant?
000204 Alfonso Fasano [Canada] ; Louis W C. Liu ; Yu-Yan Poon ; Antony E. LangInitiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model.
000205 Melissa J. Armstrong [États-Unis] ; Sarah Duff-Canning ; C. Psych [Canada] ; Matthew Kowgier [Canada] ; Connie Marras [Canada]Independent application of montreal cognitive assessment/mini-mental state examination conversion.
000223 Isabelle Beaulieu-Boire [Canada] ; Alfonso Fasano [Canada]Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
000264 Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Anthony E. Lang [Canada]Disease-modifying strategies for Parkinson's disease.
000294 Camila Catherine Aquino [Canada] ; Susan H. FoxClinical spectrum of levodopa-induced complications.
000317 Kaviraja Udupa [Canada] ; Ayda Ghahremani [Canada] ; Robert Chen [Canada]Are we close to the advent of closed loop deep brain stimulation in Parkinson's disease?
000340 John C. Steele ; Robert Wresch [États-Unis] ; Samuel D. Hanlon [États-Unis] ; Jay Keystone [Canada] ; Yoav Ben-Shlomo [Royaume-Uni]A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam.
000379 Connie Marras [Canada] ; Alexander I. Tröster ; Jaime Kulisevsky ; Glenn T. StebbinsThe tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.
000401 Alfonso Fasano [Canada] ; Andres M. LozanoThe FM/AM world is shaping the future of deep brain stimulation.
000402 Connie Marras [Canada] ; Rachel Saunders-Pullman [États-Unis]The Complexities of Hormonal Influences and Risk of Parkinson’s Disease
000423 Antonio P. Strafella [Canada] ; David BurnScience to practice: Imaging tools to study cognition in Parkinson's disease.
000432 Alfonso Fasano [Canada] ; Andres M. LozanoReply: the FM/AM world is shaping the future of deep brain stimulation.
000640 Anthony E. Lang [Canada]Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapies.
000762 Anand I. Rughani [Canada] ; Andres M. LozanoSurgical treatment of myoclonus dystonia syndrome.
000765 Kaviraja Udupa [Canada] ; Susan H. FoxSubthalamic nucleus and striatum: the red and green signals to regulate the traffic of basal ganglia circuitry.
000819 Mateusz Zurowski [Canada] ; William M. Mcdonald [États-Unis] ; Susan Fox [Canada] ; Laura Marsh [États-Unis]Psychiatric Comorbidities in Dystonia: Emerging Concepts
000843 Alberto Albanese [Italie] ; Kailash Bhatia [Royaume-Uni] ; Susan B. Bressman [États-Unis] ; Mahlon R. Delong [États-Unis] ; Stanley Fahn [États-Unis] ; Victor S. C. Fung [Australie] ; Mark Hallett [États-Unis] ; Joseph Jankovic [États-Unis] ; H. A. Jinnah [États-Unis] ; Christine Klein [Allemagne] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Jan K. Teller [États-Unis]Phenomenology and classification of dystonia: a consensus update
000904 Anthony E. Lang [Canada] ; Shirley Eberly ; Christopher G. Goetz ; Glenn Stebbins ; David Oakes ; Ken Marek ; Bernard Ravina ; Caroline M. Tanner ; Ira ShoulsonMovement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
000918 Connie Marras [Canada] ; Melissa J. Armstrong [Canada] ; Christopher A. Meaney [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; William Reginold [Canada] ; David F. Tang-Wai [Canada] ; David Gill [États-Unis] ; Paul J. Eslinger [États-Unis] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; Fred J. Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin T. Mast [États-Unis] ; Adam T. Gerstenecker [États-Unis] ; Sandra Weintraub [États-Unis] ; Sarah Duff-Canning [Canada]Measuring Mild Cognitive Impairment in Patients With Parkinson’s Disease
000957 Ludy C. Shih [États-Unis] ; Veronique G. Vanderhorst [États-Unis] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada, France]Improvement of Pisa syndrome with contralateral pedunculopontine stimulation
000A51 Susan Fox [Canada]Commentary.
000A62 Janice C. Wong [Canada] ; Melissa J. Armstrong ; Anthony E. Lang ; Lili-Naz HazratiClinicopathological review of pallidonigroluysian atrophy.
000B73 Thomas D. Steeves [Canada] ; Lundy Day ; Jonathan Dykeman ; Nathalie Jette ; Tamara PringsheimThe prevalence of primary dystonia: a systematic review and meta-analysis.
000E47 Lili-Naz Hazrati [Canada] ; Janice C. Wong ; Clement Hamani ; Andres M. Lozano ; Yu-Yan Poon ; Jonathan O. Dostrovsky ; William D. Hutchison ; Cindy Zadikoff ; Elena MoroClinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation.
000E99 Binit B. Shah [Canada] ; Anthony E. LangAcquired neurosyphilis presenting as movement disorders.
000F44 Matthew B. Stern [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche]Toward a Redefinition of Parkinson's Disease
000F48 Thomas D. Steeves [Canada] ; Lundy Day [Canada] ; Jonathan Dykeman [Canada] ; Nathalie Jette [Canada] ; Tamara Pringsheim [Canada]The Prevalence of Primary Dystonia: A Systematic Review and Meta-analysis
000F50 William Reginold [Canada] ; Melissa J. Armstrong [Canada] ; Sarah Duff-Canning [Canada] ; Anthony Lang [Canada] ; David Tang-Wai [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; Connie Marras [Canada]The Pill Questionnaire in a Nondemented Parkinson's Disease Population
000F56 Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada]The Neurobiology and Neural Circuitry of Cognitive Changes in Parkinson's Disease Revealed by Functional Neuroimaging
000F57 Tamara Pringsheim [Canada] ; Katie Wiltshire [Canada] ; Lundy Day [Canada] ; Jonathan Dykeman [Canada] ; Thomas Steeves [Canada] ; Nathalie Jette [Canada]The Incidence and Prevalence of Huntington's Disease: A Systematic Review and Meta-analysis
001013 Alfonso Fasano [Italie] ; Anabela Valadas [Portugal, Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; L. K. Prashanth [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Francesca Morgante [Italie] ; Daniel Tarsy [États-Unis] ; Andrew P. Duker [États-Unis] ; Paolo Girlanda [Italie] ; Anna Rita Bentivoglio [Italie] ; Alberto J. Espay [États-Unis]Psychogenic Facial Movement Disorders: Clinical Features and Associated Conditions
001021 Andrew Siderowf [États-Unis] ; Anthony E. Lang [Canada]Premotor Parkinson's Disease: Concepts and Definitions
001030 Andrew Lees (neurologue) [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis]Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease
001058 Igor N. Petrovic [Royaume-Uni] ; Helen Ling [Royaume-Uni, Serbie] ; Yasmine Asi [Serbie] ; Zeshan Ahmed [Serbie] ; Prashanth L. Kukkle [Canada] ; Lili-Naz Hazrati [Canada] ; Anthony E. Lang [Canada] ; Tamas Revesz [Serbie] ; Janice L. Holton [Serbie] ; Andrew Lees (neurologue) [Royaume-Uni, Serbie]Multiple System Atrophy- Parkinsonism with Slow Progression and Prolonged Survival: A Diagnostic Catch
001067 Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France]Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
001069 Aron S. Buchman [États-Unis] ; Sukriti Nag [États-Unis] ; Joshua M. Shulman [États-Unis] ; Andrew S. P. Lim [Canada] ; Veronique G. J. M. Vanderhorst [États-Unis] ; Sue E. Leurgans [États-Unis] ; Julie A. Schneider [États-Unis] ; David A. Bennett [États-Unis]Locus Coeruleus Neuron Density and Parkinsonism in Older Adults Without Parkinson's Disease
001089 Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased Levels of 5-HT1A Receptor Binding in Ventral Visual Pathways in Parkinson's Disease
001110 Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Jane A. Hoppin [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; David M. Umbach [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie B. Richards [États-Unis] ; Dale P. Sandler [États-Unis] ; Aaron Blair [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis]Genetic Modification of the Association of Paraquat and Parkinson's Disease
001140 Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis]Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease
001166 Lili-Naz Hazrati [Canada] ; Janice C. Wong [Canada] ; Clement Hamani [Canada] ; Andres M. Lozano [Canada] ; Yu-Yan Poon [Canada] ; Jonathan O. Dostrovsky [Canada] ; William D. Hutchison [Canada] ; Cindy Zadikoff [Canada, États-Unis] ; Elena Moro [Canada]Clinicopathological Study in Progressive Supranuclear Palsy With Pedunculopontine Stimulation
001220 Binit B. Shah [Canada] ; Anthony E. Lang [Canada]Acquired Neurosyphilis Presenting as Movement Disorders
001237 Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
001238 Binit B. Shah [Canada] ; Anthony E. Lang [Canada]A Case of Neurosyphilis Presenting with Myoclonus, Cerebellar Ataxia, and Speech Disturbance
001305 Pascal H. H. M. Van Lieshout [Canada] ; Catriona M. Steele [Canada] ; Anthony E. Lang [Canada]Tongue control for swallowing in Parkinson's disease: Effects of age, rate, and stimulus consistency
001323 Francisco A. Ponce [États-Unis] ; Andres M. Lozano [Canada]The most cited works in Parkinson's disease
001324 Dustin A. Heldman [États-Unis] ; Joseph P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Alberto J. Espay [États-Unis]The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measures
001334 Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada]The curious case of phenocopies in families with genetic Parkinson's disease
001344 Andres M. Lozano [Canada]The Wilson films — Hemiballism
001377 Philip A. Starr [États-Unis] ; Paul Bejjani [Liban] ; Andres M. Lozano [Canada] ; Leo Verhagen Metman [États-Unis] ; And Marwan I. Hariz [Royaume-Uni]Stereotactic techniques and perioperative management of DBS in dystonia
001419 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long‐term clinical trials
001447 Anthony E. Lang [Canada] ; Valerie Voon [Royaume-Uni]Psychogenic movement disorders: Past developments, current status, and future directions
001456 Stéphane Thobois [France] ; Takaomi Taira [Japon] ; Cynthia Comella [États-Unis] ; Elena Moro [Canada] ; Susan Bressman [États-Unis] ; And Alberto Albanese [Italie]Pre‐operative evaluations for DBS in dystonia
001459 Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
001473 Roberto Cilia [Canada, Italie] ; Sang Soo Cho [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; Ji Hyun Ko [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada]Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis
001491 Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
001521 Marjan Jahanshahi [Royaume-Uni] ; Virginie Czernecki [France] ; And Mateusz Zurowski [Canada]Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia
001549 Arpan R. Mehta [Canada, Royaume-Uni] ; Susan H. Fox [Canada] ; Mark Tarnopolsky [Canada] ; Grace Yoon [Canada]Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype
001562 Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]Milestones in Parkinson's disease therapeutics
001620 Helen Bronte-Stewart [États-Unis] ; Takaomi Taira [Japon] ; Francesc Valldeoriola [Espagne] ; Marcello Merello [Argentine] ; William J. Marks Jr. [États-Unis] ; Alberto Albanese [Italie] ; Susan Bressman [États-Unis] ; And Elena Moro [Canada]Inclusion and exclusion criteria for DBS in dystonia
001643 Elena Moro [Canada] ; Alberto Albanese [Italie] ; Joachim K. Krauss [Allemagne] ; Leo Verhagen Metman [États-Unis] ; Marie Vidailhet [France] ; Marwan I. Hariz [Royaume-Uni]Guest Editors' introduction
001668 Melissa J. Armstrong [Canada] ; Binit B. Shah [Canada] ; Robert Chen [Canada] ; Michael J. Angel [Canada] ; Anthony E. Lang [Canada]Expanding the phenomenology of benign hereditary chorea: Evolution from chorea to myoclonus and dystonia
001684 Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine
001686 Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne]Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting
001704 Alberto J. Espay [États-Unis] ; Joe P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Emily Dunn [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Dustin A. Heldman [États-Unis]Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease
001715 Anthony E. Lang [Canada]Deep brain stimulation for dystonia
001725 Victor Peralta [Espagne] ; Anthony E. Lang [Canada]Crossing the borders between neurology and psychiatry in functional neurological disorders
001846 Anthony E. Lang [Canada]A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
001881 Helen Bronte-Stewart [États-Unis] ; Takaomi Taira [Japon] ; Francesc Valldeoriola [Espagne] ; Marcello Merello [Argentine] ; William J. Jr Marks [États-Unis] ; Alberto Albanese [Italie] ; Susan Bressman [États-Unis] ; Elena Moro [Canada]Inclusion and Exclusion Criteria for DBS in Dystonia
001991 Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada]Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)
001A01 I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada]Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region
001B40 Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni]Olfactory heterogeneity in LRRK2 related Parkinsonism
001B56 Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song LuNeuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia
001B99 Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada]Long‐term effect of unilateral pallidotomy on levodopa‐induced dyskinesia
001C27 Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
001C31 Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada]Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders
001D21 Alberto J. Espay [États-Unis] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease
001D24 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis
001D30 Amitabh Gupta [Canada] ; Anthony E. Lang [Canada]Drug‐induced cranial myoclonus
001D33 Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
001D58 Terence D. Sanger [États-Unis] ; Daofen Chen [États-Unis] ; Darcy L. Fehlings [Canada] ; Mark Hallett [États-Unis] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Harvey S. Singer [États-Unis] ; Katharine Alter [États-Unis] ; Hilla Ben-Pazi [Israël] ; Erin E. Butler [États-Unis] ; Robert Chen [Canada] ; Abigail Collins [États-Unis] ; Sudarshan Dayanidhi [États-Unis] ; Hans Forssberg [Suède] ; Eileen Fowler [États-Unis] ; Donald L. Gilbert [États-Unis] ; Sharon L. Gorman [États-Unis] ; Mark E. Gormley Jr. [États-Unis] ; H. A. Jinnah [États-Unis] ; Barbara Kornblau [États-Unis] ; Kristin J. Krosschell [États-Unis] ; Rebecca K. Lehman [États-Unis] ; Colum Mackinnon [États-Unis] ; C. J. Malanga [États-Unis] ; Ronit Mesterman [Canada] ; Margaret Barry Michaels [États-Unis] ; Toni S. Pearson [États-Unis] ; Jessica Rose [États-Unis] ; Barry S. Russman [États-Unis] ; Dagmar Sternad [États-Unis] ; Kathy J. Swoboda [États-Unis] ; Francisco Valero-Cuevas [États-Unis]Definition and classification of hyperkinetic movements in childhood
001E05 Susanne A. Schneider [Royaume-Uni, Allemagne] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] ; Benedikt Bader [Allemagne] ; Adrian Danek [Allemagne] ; Kailash P. Bhatia [Royaume-Uni]Characteristic head drops and axial extension in advanced chorea‐acanthocytosis
001E18 Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis]Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
001E33 Andres M. Lozano [Canada] ; Brian J. Snyder [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada]Basal ganglia physiology and deep brain stimulation
001E93 Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy
001F27 Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni]Olfactory Heterogeneity in LRRK2 Related Parkinsonism
001F36 Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada]Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia
001F39 Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
001F77 Daniel Weintraub [États-Unis] ; Staci Hoops [États-Unis] ; Judy A. Shea [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Erika D. Driver-Dunckley [États-Unis] ; Charles H. Adler [États-Unis] ; Marc N. Potenza [États-Unis] ; Janis Miyasaki [Canada] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Howard I. Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Stacy S. Horn [États-Unis] ; Matthew B. Stern [États-Unis] ; Valerie Voon [États-Unis]Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
001F99 Renato P. Munhoz [Brésil] ; Helio A. Teive [Brésil] ; Alexandre N. Francisco [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada]Unilateral pallidotomy in a patient with parkinsonism and G2019S LRRK2 mutation
002059 Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada]Serotonin and Parkinson's disease: On movement, mood, and madness
002167 Alberto J. Espay [États-Unis] ; Linda M. Goldenhar [États-Unis] ; Valerie Voon [États-Unis] ; Anette Schrag [Royaume-Uni] ; Noël Burton [États-Unis] ; Anthony E. Lang [Canada]Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society members
002196 Anthony E. Lang [Canada] ; Michael Angel [Canada] ; Kailash Bhatia [Royaume-Uni] ; Robert Chen [Canada] ; Stanley Fahn [États-Unis] ; Mark Hallett [États-Unis] ; Anette Schrag [Royaume-Uni] ; Philip Thompson [Australie]Myoclonus in complex regional pain syndrome
002219 Bart F. L. Van Nuenen [Pays-Bas, Allemagne] ; Thilo Van Eimeren [Canada] ; Joyce P. M. Van Der Vegt [Pays-Bas, Allemagne] ; Carsten Buhmann [Allemagne] ; Christine Klein [Allemagne] ; Bastiaan R. Bloem [Pays-Bas] ; Hartwig R. Siebner [Allemagne, Danemark]Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach
002226 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
002237 Jonathan Kimmelman [Canada, États-Unis] ; Alex John London [États-Unis] ; Bernard Ravina [États-Unis] ; Tim Ramsay [Canada] ; Mark Bernstein [Canada] ; Alan Fine [Canada] ; Frank W. Stahnisch [Canada] ; Marina Elena Emborg [États-Unis]Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations
002257 Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis]Impulsive and compulsive behaviors in Parkinson's disease
002260 Alberto J. Espay [Canada, États-Unis] ; Dorcas E. Beaton [Canada] ; Francesca Morgante [Canada, Italie] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]Impairments of speed and amplitude of movement in Parkinson's disease: A pilot study
002483 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
002535 Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada]rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: A PET study
002578 Naomi P. Visanji [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Tom H. Johnston [Canada] ; Andrew C. Mccreary [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]The nociceptin/orphanin FQ (NOP) receptor antagonist J‐113397 enhances the effects of levodopa in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
002603 Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada]The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins
002646 Elena Moro [Canada] ; Panida Piboolnurak [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada]Reply: The variability of levodopa response in Parkinson's disease: Is sensitization reversible?
002679 Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada]Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial
002756 Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stern [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis]Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
002783 Susan H. Fox [Canada] ; Anthony E. Lang [Canada]Levodopa‐related motor complications—Phenomenology
002872 Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada]Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
002873 Jie-Yuan Li [Canada, Taïwan] ; Danny I. Cunic [Canada] ; Guillermo Paradiso [Canada] ; Carolyn Gunraj [Canada] ; Pramod K. Pal [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]Electrophysiological features of myoclonus‐dystonia
002908 Alberto J. Espay [États-Unis] ; Andrew P. Duker [États-Unis] ; Robert Chen [Canada] ; Michael S. Okun [États-Unis] ; Edwin T. Barrett [États-Unis] ; Johnna Devoto [États-Unis] ; Pamela Zeilman [États-Unis] ; Maureen Gartner [États-Unis] ; Noël Burton [États-Unis] ; Helard A. Miranda [États-Unis] ; George T. Mandybur [États-Unis] ; Theresa A. Zesiewicz [États-Unis] ; Kelly D. Foote [États-Unis] ; Fredy J. Revilla [États-Unis]Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: Preliminary observations
002A35 Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada]A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
002B55 Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Ji Hyun Ko [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada]Subdural motor cortex stimulation in Parkinson's disease does not modify movement‐related rCBF pattern
002D34 Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis]Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan
002D75 Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada]Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease
002D92 Teri R. Thomsen [Canada] ; Wendy R. Galpern [Canada, États-Unis] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada]Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease
002D95 Jie-Yuan Li [Canada, Taïwan] ; Alberto J. Espay [Canada] ; Carolyn A. Gunraj [Canada] ; Pramod K. Pal [Canada] ; Danny I. Cunic [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]Interhemispheric and ipsilateral connections in Parkinson's disease: Relation to mirror movements
002F91 Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada]Benign hereditary chorea revisited: A journey to understanding
003017 Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada]Antipsychotic use in older adults with Parkinson's disease
003105 Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada]Benign Hereditary Chorea Revisited : A Journey to Understanding
003224 Alberto J. Espay [Canada, États-Unis] ; Catherine Bergeron [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada]Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion
003277 Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
003283 Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France]Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
003308 Satoshi Kaneko [Japon] ; Toshitaka Kawarai [Canada] ; Edwin Yip [Canada] ; Shabnam Salehi-Rad [Canada] ; Christine Sato [Canada] ; Antonio Orlacchio [Italie] ; Giorgio Bernardi [Italie] ; Yan Liang [Canada] ; Hiroshi Hasegawa [Canada] ; Ekaterina Rogaeva [Canada] ; Peter St George-Hyslop [Canada]Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia
003415 Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] ; Ali R. Rezai [États-Unis]Guest editors' introduction
003492 Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
003531 Renato P. Munhoz [Brésil] ; Toshitaka Kawarai [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Christine Sato [Canada] ; Yan Liang [Canada] ; Peter H. St. George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada]Clinical and genetic study of a Brazilian family with spastic paraplegia (SPG6 locus)
003571 Jens Volkmann [Allemagne] ; Elena Moro [Canada] ; Rajesh Pahwa [États-Unis]Basic algorithms for the programming of deep brain stimulation in Parkinson's disease
003809 Adrian P. Fawcett [Canada] ; Elena Moro [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease
003892 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
003978 Antonio Orlacchio [Italie] ; Toshitaka Kawarai [Canada] ; Fabrizio Gaudiello [Italie] ; Antonio Totaro [Italie] ; Orazio Schillaci [Italie] ; Alessandro Stefani [Italie] ; Roberto Floris [Italie] ; Peter H. St. George-Hyslop [Canada] ; Sandro Sorbi [Italie] ; Giorgio Bernardi [Italie]Clinical and genetic study of a large SPG4 Italian family
003A24 Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; Yan Meng [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada]Analysis of the glucocerebrosidase gene in Parkinson's disease
003A27 Galit Kleiner-Fisman [États-Unis] ; Noel Y. Calingasan [États-Unis] ; Mary Putt [États-Unis] ; June Chen [États-Unis] ; M. Flint Beal [États-Unis] ; Anthony E. Lang [Canada]Alterations of striatal neurons in benign hereditary chorea
003A76 Galit Kleiner-Fisman [États-Unis] ; Noel Y. Calingasan [États-Unis] ; Mary Putt [États-Unis] ; June Chen [États-Unis] ; M. Flint Beal [États-Unis] ; Anthony E. Lang [Canada]Alterations of striatal neurons in benign hereditary chorea
003B17 Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada]Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations
003B25 Renato P. Munhoz [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada]Sporadic case of dentatorubral pallidoluysian atrophy with no CAG repeat expansion and no intranuclear inclusions
003B73 Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada]Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
003B88 Galit Kleiner-Fisman [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada]Presentation of Creutzfeldt–Jakob disease as acute corticobasal degeneration syndrome
003C23 Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada]Parkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort
003C44 Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada]Neuronal activity in the globus pallidus of multiple system atrophy patients
003C69 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
003D03 Renato P. Munhoz [Canada] ; Anthony E. Lang [Canada]Gestes antagonistes in psychogenic dystonia
003D34 Yih-Ru Wu [Taïwan] ; Guey-Jen Lee-Chen [Taïwan] ; Anthony E. Lang [Canada] ; Chiung-Mei Chen [Taïwan] ; Hsuan-Yuan Lin [Taïwan] ; Sien-Tsong Chen [Taïwan]Dystonia as a presenting sign of spinocerebellar ataxia type 1
003D42 Katja Hedrich [Allemagne] ; Cordula Eskelson [Allemagne] ; Beth Wilmot [États-Unis] ; Karen Marder [États-Unis] ; Juliette Harris [États-Unis] ; Jennifer Garrels [Allemagne] ; Helen Meija-Santana [États-Unis] ; Peter Vieregge [Allemagne] ; Helfried Jacobs [Allemagne] ; Susan B. Bressman [États-Unis] ; Anthony E. Lang [Canada] ; Martin Kann [Allemagne] ; Giovanni Abbruzzese [Italie] ; Paolo Martinelli [Italie] ; Eberhard Schwinger [Allemagne] ; Laurie J. Ozelius [États-Unis] ; Peter P. Pramstaller [Italie, États-Unis] ; Christine Klein [Allemagne] ; Patricia Kramer [États-Unis]Distribution, type, and origin of Parkin mutations: Review and case studies
003E40 Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada]Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations
003E46 Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni]Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man
003E49 Galit Kleiner-Fisman [Canada] ; Catherine Bergeron [Canada] ; Anthony E. Lang [Canada]Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome
003E53 Adrian P. Fawcett [Canada] ; Ilena Moro [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease
003E82 Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; YAN MENG [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada]Analysis of the glucocerebrosidase gene in Parkinson's disease
003F00 Alberto J. Espay [Canada] ; Peter Ashby [Canada] ; Ritsuko Hanajima [Canada] ; Mandar S. Jog [Canada] ; Anthony E. Lang [Canada]Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin
003F96 Daniel S. Sa [Canada] ; Angela Mailis-Gagnon [Canada] ; Keith Nicholson [Canada] ; Anthony E. Lang [Canada]Posttraumatic painful torticollis
004029 Galit Kleiner-Fisman [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada]Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist
004058 Zelma H. T. Kiss [Canada] ; Marshall Wilkinson [Canada] ; Jerry Krcek [Canada] ; Oksana Suchowersky [Canada] ; Bin. Hu [Canada] ; William F. Murphy [Canada] ; Doug Hobson [Canada] ; Ron R. Tasker [Canada]Is the target for thalamic deep brain stimulation the same as for thalamotomy?
004116 Ronald B. Postuma [États-Unis] ; Yoshiaki Furukawa [Canada, États-Unis] ; Ekaterina Rogaeva [Canada, États-Unis] ; Peter H. St. George-Hyslop [Canada, États-Unis] ; Matt J. Farrer [Canada, États-Unis] ; Anthony E. Lang [États-Unis]Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin?
004137 Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada]Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study
004166 Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada]Burden of parkinsonism: A population‐based study
004187 Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada]Acute effect of transcutaneous electrical nerve stimulation on tremor
004210 Galit Kleiner-Fisman [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada]Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist
004276 Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis]Surgery of the motor thalamus: Problems with the present nomenclatures
004384 Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Microelectrode recordings in the pallidum
004389 Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Mechanisms of deep brain stimulation
004514 Anthony E. Lang [Canada] ; Hakan Widner [Suède]Deep brain stimulation for Parkinson's disease: Patient selection and evaluation
004532 Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
004535 Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical–Pathological study of levodopa complications
004668 Andres M. Lozano [Canada]The subthalamic nucleus: Myth and opportunities
004776 D. A. Grimes [Canada] ; D. Bulman [Canada] ; P. St. George-Hyslop [Canada] ; A. E. Lang [Canada]Inherited myoclonus‐dystonia: Evidence supporting genetic heterogeneity
004826 Y. R. Wu [Taïwan] ; R. Levy [Canada] ; P. Ashby [Canada] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada]Does stimulation of the GPi control dyskinesia by activating inhibitory axons?
004874 Neil R. Cashman [Canada]Amyotrophic Lateral Sclerosis. Robert H. Brown, Jr., Vincent Meininger, and Michael Swash, eds.
004886 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Lee Cyn Ang [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche]69‐Year‐old man with gait disturbance and parkinsonism
004A17 Jean A. Saint-Cyr [Canada] ; Lisa L. Trépanier [Canada]Neuropsychologic assessment of patients for movement disorder surgery
004B20 Connie Marras [Canada] ; Annette V. Nieves [Canada]Book reviews
004B48 Christopher Dromey [Canada] ; Rajeev Kumar [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada]An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice
004B63 Brian M. Ross [Canada] ; Klaus Eder [Allemagne] ; Anna Moszczynska [Canada] ; Nikolaos Mamalias [Canada] ; Jacques Lamarche [Canada] ; Lee Ang [Canada] ; Massimo Pandolfo ; Guy Rouleau [Canada] ; Manfred Kirchgessner [Allemagne] ; Stephen J. Kish [Canada]Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type‐1
004B78 Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada]Neuropsychologic assessment of patients for movement disorder surgery
004C30 Michael D. Hill [Canada] ; Rajeev Kumar [Canada] ; Andres Lozano [Canada] ; Charles H. Tator [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada]Syringomyelic dystonia and athetosis
004D45 Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Esther Cubo [États-Unis]Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state
004D57 Robert Chen [États-Unis, Canada] ; Barbara I. Karp [États-Unis] ; Susanne R. Goldstein [États-Unis] ; William Bara-Jimenez [États-Unis] ; Zaneb Yaseen [États-Unis] ; Mark Hallett [États-Unis]Effect of muscle activity immediately after botulinum toxin injection for writer's cramp
004E14 Barbara Illowsky Karp [Canada] ; Susanne R. Goldstein [Canada] ; Robert Chen [Canada] ; Ali Samii [États-Unis] ; William Bara-Jimenez [Canada] ; Mark Hallett [Canada]An open trial of clozapine for dystonia
004E57 B. I. Karp [États-Unis, Canada] ; S. R. Goldstein [États-Unis, Canada] ; R. Chen [États-Unis, Canada] ; A. Samii [États-Unis] ; W. Bara-Jimenez [États-Unis, Canada] ; M. Hallett [États-Unis, Canada]An open trial of clozapine for dystonia
004F36 Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada]Pallidotomy for Tremor
004F68 Ali H. Rajput [Canada] ; Alex Rajput [Canada] ; Anthony E. Lang [Canada] ; Rajeev Kumar [Canada] ; Ryan J. Uitti [États-Unis] ; David G. Le Couteur [Australie] ; Sally J. Mccann [Australie] ; Mark W. Becher [États-Unis] ; Christopher A. Ross [États-Unis] ; Richard Hardie [Royaume-Uni]Letters to the Editor
005061 Klaus Eder [Allemagne] ; Stephen J. Kish [Canada] ; Manfred Kirchgessner [Allemagne] ; Ross [Canada]Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type‐1
005272 A. Strafella [Canada] ; Ashby [Canada] ; A. E. Lang [Canada]Reflex myoclonus in cortical‐basal ganglionic degeneration involves a transcortical pathway
005322 Anthony Feinstein [Canada] ; C. M. Sue [Australie] ; J. G. L. Morris [Australie] ; John G. Nutt [États-Unis] ; Stephen T. Gancher [États-Unis] ; Anthony E. Lang [Canada] ; Tetsuo Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis]Letters to the editor
005331 Antonio Strafella [Canada] ; Ashby [Canada] ; Michael Munz [Canada] ; John O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada]Inhibition of voluntary activity by thalamic stimulation in humans: Relevance for the control of tremor
005413 Singer [États-Unis] ; Anthony E. Lang [Canada] ; Oksana Suchowersky [Canada]Adult‐onset subacute sclerosing panencephalitis: Case reports and review of the literature
005543 C. Singer [États-Unis] ; A. E. Lang [Canada] ; O. Suchowersky [Canada]Adult-onset subacute sclerosing panencephalitis : Case reports and review of the literature
005624 Elan D. Louis [États-Unis] ; Kenji Nakashima [Japon] ; Masayoshi Kusumi [Japon] ; Kazuro Takahashi [Japon] ; Yuichi Inoue [Japon] ; Ryan J. Uitti [États-Unis] ; J. Eric Ahlskog [États-Unis] ; D. M. Maraganore [États-Unis] ; Anthony E. Lang [Canada]Letters to the editor
005689 Lucien Bettendorff [Belgique] ; Frank Mastrogiacomo [Canada] ; Jacques Lamarche [Canada] ; Slobodan Dioži [Yougoslavie] ; Kish [Canada]Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1
005804 Lisa M. Shulman [États-Unis] ; Anthony E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; Noble J. David [États-Unis] ; Weiner [États-Unis]What is it?. Case 1, 1995: Psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction
005825 Lenz [États-Unis] ; S. L. Normand [États-Unis] ; H. C. Kwan [Canada] ; D. Andrews [Canada] ; L. H. Rowland [États-Unis] ; M. W. Jones [États-Unis] ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada] ; Y. E. Lenz [États-Unis]Statistical prediction of the optimal site for thalamotomy in parkinsonian tremor
005881 Perminder Sachdev [Australie] ; Anthony E. Lang [Canada]Letters to the editor
005897 Lang [Canada]Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome
005B01 Thomas R. Zimmerman Jr. [États-Unis] ; Jacob I. Sage [États-Unis] ; Anthony E. Lang [Canada] ; Mark [États-Unis]Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment
005D33 Tatton [Canada]Selegiline can mediate neuronal rescue rather than neuronal protection
006289 Shandling [Canada] ; P. L. Carlen [Canada] ; A. E. Lang [Canada]Parkinsonism in alcohol withdrawal: A follow‐up study
006331 Lewis [Canada] ; M. J. Gawel [Canada]Diffuse lewy body disease with dementia and oculomotor dysfunction
006603 M. Guttman [Canada] ; Lang [Canada] ; E. S. Garnett [Canada] ; C. Nahmias [Canada] ; G. Firnau [Canada] ; F. J. Tyndel [Canada] ; A. S. Gordon [Canada]Regional cerebral glucose metabolism in SLE chorea: Further evidence that striatal hypometabolism is not a correlate of chorea

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024